Multiple Sclerosis Relapse
Multiple Sclerosis Relapse refers to a period when symptoms of multiple sclerosis worsen or new symptoms appear, often leading to increased disability. This condition can affect various functions of the nervous system.
We are comparing a new biosimilar treatment to Ocrevus for people with relapsing multiple sclerosis. The study aims to evaluate how well it works and its safety profile.
Health conditions and diseases that the clinical trial is designed to study and treat.
Multiple Sclerosis Relapse refers to a period when symptoms of multiple sclerosis worsen or new symptoms appear, often leading to increased disability. This condition can affect various functions of the nervous system.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.